Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: a case series
International Journal of Dermatology · 2025-03 · 64 (3) · 623-625
DOI: 10.1111/ijd.17512 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 06.10.2024. Verfasst von Calvo-Asín Carlos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital Universitario 12 de Octubre, I+12 Research Institute, Universidad Complutense, Madrid, Spain. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
The data supporting this study's findings are available from the corresponding author upon reasonable request.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Hospital Universitario 12 de Octubre, I+12 Research Institute, Universidad Complutense, Madrid, Spain.
ORCID-Profile: Calvo-Asín Carlos
Zitieren
APA
Carlos, C. A., Tous-Romero, F., García-Donoso, C., Puig-Buendia, J., Borja, G. R., Cavestany-Rodríguez, R., & Rivera-Díaz, R. (2025). Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: a case series. International Journal of Dermatology, 64(3), 623-625. https://doi.org/10.1111/ijd.17512
Vancouver
Carlos CA, Tous-Romero F, García-Donoso C, Puig-Buendia J, Borja GR, Cavestany-Rodríguez R, et al. Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: a case series. International Journal of Dermatology. 2025;64(3):623-625. doi:10.1111/ijd.17512
BibTeX
@article{Carlos2025,
author = {Carlos, Calvo-Asín and Tous-Romero, Fátima and García-Donoso, Carmen and Puig-Buendia, Jose and Borja, González-Rodríguez and Cavestany-Rodríguez, Raquel and Rivera-Díaz, Raquel},
title = {Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: a case series},
journal = {International Journal of Dermatology},
year = {2025},
volume = {64},
number = {3},
pages = {623--625},
doi = {10.1111/ijd.17512}
}
EUVIMED